ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Nektar Therapeutics

Nektar Therapeutics (NKTR)

0.9342
0.0491
(5.55%)
Closed March 29 04:00PM
0.9001
-0.0341
(-3.65%)
After Hours: 07:02PM

Nektar Therapeutics Financial Summary

The current NKTR market cap is 165.27M. The company's latest EPS is USD -1.5034 and P/E is -0.63.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 23.63M22.02M21.59M20.5M24.14M
Operating Income -154.66M9.97M-134.71M-50.6M-14.31M
Net Income -59.05M-59.69M-137.02M-51.12M-45.84M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 114.62M152.92M101.91M92.06M90.12M
Operating Income -440.04M-379.92M-446.1M-313.73M-263.68M
Net Income -440.67M-444.44M-523.84M-368.2M-276.06M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 781.01M710.6M561.74M494.28M442.24M
Total Liabilities 368.78M343.96M320.88M297.32M282.88M
Total Equity 412.22M366.64M240.87M196.96M159.37M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.98B1.54B1.12B710.6M398.03M
Total Liabilities 571.97M461.47M437.68M343.96M267.05M
Total Equity 1.41B1.08B679.51M366.64M130.99M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -246.3M-304.01M-51.92M-103.44M-145.56M
Investing 325.82M365.84M40.6M65.77M122.18M
Financing 1.41M1.51M N/A 18k18k
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -328.68M-313.29M-412.66M-304.01M-192.61M
Investing 206.89M496.21M202.78M365.84M139.56M
Financing 23.36M-80.35M36.24M1.51M30k
Market Cap 165.27M
Price to Earnings Ratio -0.63
Price to Sales Ratio 1.92
Price to Cash Ratio 4.89
Price to Book Ratio 1.32
Dividend Yield -

Share Statistics

Shares Outstanding 183.62M
Average Volume (1 week) 1.19M
Average Volume (1 Month) 2.57M
52 Week Change 16.29%
52 Week High 1.12
52 Week Low 0.4126
Spread (Intraday) 0.02 (2.34%)

Company Info

Company Name Nektar Therapeutics
Address 1209 orange street
wilmington, delaware 19801
Website https://www.nektar.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock